Xebra Brands Ltd. (TSE:XBRA) has released an update.
Xebra Brands Ltd., a prominent cannabis company, has received approval from COFEPRIS for a second CBD product to be sold in Mexico, marking a significant step in expanding their market presence. The company’s latest 250mg Tincture is part of their commitment to meeting the growing demand for high-quality CBD products in the region. With this new product, Xebra Brands continues to solidify its position as a leader in the Mexican CBD industry, aiming to cater to the wellness needs of Mexico’s sizable population.
For further insights into TSE:XBRA stock, check out TipRanks’ Stock Analysis page.
